The therapeutic efficacy of radical prostatectomy and external beam radiation therapy in patients with different pathological patterns of prostate cancer

Background: We aim to investigate the prognostic value of different pathological patterns of nonadenocarcinoma prostate cancers (PCa) in radical prostatectomy (RP) and external beam radiation therapy (EBRT).Methods: Data of 470,258 localized PCa patients between 2004 and 2016 were collected from the Surveillance, Epidemiology, and End Results database. Propensity score matching was performed to balance the baseline characteristics of patients in different groups. Kaplan-Meier curves and Cox regression were used for survival analysis. Overall survival (OS) and cancer-specific survival (CSS) were set as endpoints. Results: Totally, 1044 patients with non-adenocarcinoma patterns of PCa were included. Patients with small cell neuroendocrine carcinoma (SCNC) and neuroendocrine differentiation (NED) harbored the worst prognosis in both RP and EBRT among all pathological groups. RP exhibited superior effects to EBRT for this group of cases. Ductal carcinoma (DA) was also related to poorer survival outcomes versus PAC in both local therapies. Yet, for men with DA, both RP and EBRT still improved patients' prognosis against no local therapy (NLT), with RP being the superior modality. Cases harboring mucinous adenocarcinoma (MA) and signet ring cell carcinoma (SRCC) shared comparable clinical outcomes to men with PAC. However, for cases with MA, neither RP nor EBRT was related to better survival outcomes against NLT, while for patients with SRCC, both RP and EBRT prolonged patients' survival with similar effects. Conclusions: Our study provided a comprehensive view of the treatment effect of RP and EBRT in nonadenocarcinoma PCa patients. These findings could facilitate clinicians in making therapeutic decisionmaking for non-adenocarcinoma patients.(c) 2022 Asian Surgical Association and Taiwan Robotic Surgery Association. Publishing services by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/ licenses/by-nc-nd/4.0/).

Automated summary

This study aimed to investigate the treatment effect of radical prostatectomy (RP) and external beam radiation therapy (EBRT) in nonadenocarcinoma prostate cancer (PCa) patients. The results showed that patients with small cell neuroendocrine carcinoma (SCNC) and neuroendocrine differentiation (NED) had the worst prognosis, while patients with ductal carcinoma (DA) also had poorer survival outcomes. Patients with mucinous adenocarcinoma (MA) and signet ring cell carcinoma (SRCC) had comparable clinical outcomes to those with adenocarcinoma.